ESMO Clinical Practice Guidelines: Urogenital cancers

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Latest enhanced and revised set of guidelines

ESMO has Clinical Practice Guidelines on the following Urogenital Cancers: Prostate cancer, Bladder cancer, Renal cell cancer (RCC) and Testicular seminoma and non-seminoma. They include information on incidence,  diagnosis, staging and risk assessment,  treatment, response evaluation and follow-up.

Prostate cancer

Published in 2010
Authors: A. Horwich, C. Parker, C. Bangma, V. Kataja
Read the guideline in PDF

Bladder cancer

Published in 2011
Authors: J. Bellmunt, A. Orsola, T. Wiegel, M. Guix, M. De Santis, V. Kataja
Read the guideline in PDF

Renal cell cancer

Published in 2012
Authors: B. Escudier, T. Eisen, C. Porta, J. J. Patard, V. Khoo, F. Algaba, P. Mulders, V. Kataja
Read the guideline in PDF

Testicular seminoma

Published in 2010
Authors: H.-J. Schmoll, K. Jordan, R. Huddart, M. P. Laguna, A. Horwich, K. Fizazi and V. Kataja
Read the guideline in PDF

Testicular non-seminoma

Published in 2010
Authors: H.-J. Schmoll, K. Jordan, R. Huddart, M. P. Laguna, A. Horwich, K. Fizazi and V. Kataja
Read the guideline in PDF